74 related articles for article (PubMed ID: 8087485)
21. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada.
Hendry JH; Roberts SA; Slevin NJ; Keane TJ; Barton MB; Agren-Cronqvist A
Radiother Oncol; 1994 Apr; 31(1):14-22. PubMed ID: 8041895
[TBL] [Abstract][Full Text] [Related]
22. Fifth progress report on the British Institute of Radiology fractionation trial of 3F-week or 5F-week treatment of larynx and pharynx.
Wiernik G; Bleehen NM; Brindle J; Meredith-Brown D; Churchill-Davidson IF; Davidson JC; Finney R; Fowler JF; Hadden RC; Halnan KE; Haybittle JL; Lansley IF; Howard N; O'Connell D; Phillips DL; Sambrock DK; Shanks W; Sicher K; Skeggs D; Stewart MA; Tudway RC
Br J Radiol; 1972 Oct; 45(538):754-6. PubMed ID: 4562371
[No Abstract] [Full Text] [Related]
23. The impact of delivered dose errors on local control of irradiated advanced laryngeal cancer.
Miszczyk L; Tarnawski R; Składowski K
Neoplasma; 2000; 47(2):133-6. PubMed ID: 10985482
[TBL] [Abstract][Full Text] [Related]
24. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
Roberts SA; Hendry JH; Swindell R; Wilkinson JM; Hunter RD
Radiother Oncol; 2004 Jan; 70(1):63-74. PubMed ID: 15036854
[TBL] [Abstract][Full Text] [Related]
25. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
26. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
27. [Timing and duration of postoperative radiotherapy in patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A; Stryczyńska G
Otolaryngol Pol; 2002; 56(3):307-11. PubMed ID: 12162018
[TBL] [Abstract][Full Text] [Related]
28. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
29. [Results of radiotherapy in elderly patients with early laryngeal cancer].
Szyszka-Charewicz B; Pudełek K; Skołyszewski J; Skóra T
Otolaryngol Pol; 2007; 61(4):387-93. PubMed ID: 18260219
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules.
Wyatt RM; Jones BJ; Dale RG
Br J Radiol; 2008 Jul; 81(967):549-63. PubMed ID: 18378526
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: results of the phase 3 ARCON trial.
Janssens GO; van Bockel LW; Doornaert PA; Bijl HP; van den Ende P; de Jong MA; van den Broek GB; Verbist BM; Terhaard CH; Span PN; Kaanders JH
Eur J Cancer; 2014 Apr; 50(6):1112-9. PubMed ID: 24424106
[TBL] [Abstract][Full Text] [Related]
32. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
33. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
[TBL] [Abstract][Full Text] [Related]
34. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
35. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data.
Roberts SA; Hendry JH
Radiother Oncol; 1993 Oct; 29(1):69-74. PubMed ID: 8295990
[TBL] [Abstract][Full Text] [Related]
36. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
[TBL] [Abstract][Full Text] [Related]
37. [Prospective clinical study of twice-a-day fractionation radiotherapy in head and neck cancer].
Okawa T; Akita Y; Hattori H; Takanaka T; Kashihara K; Kita M
Gan No Rinsho; 1988 Oct; 34(13):1768-72. PubMed ID: 3199513
[TBL] [Abstract][Full Text] [Related]
38. [Dose multifractionation in radiotherapy of laryngeal cancer].
Andreev VG; Ivanov VK; Mardynskiĭ IuS; Sysoev AS; Iglin AV
Med Radiol (Mosk); 1987 Apr; 32(4):7-10. PubMed ID: 3586913
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy as the primary approach in the treatment of laryngeal cancer.
Jankovic I; Merkas Z
Can J Otolaryngol; 1975; 4(5):919-26. PubMed ID: 1203798
[TBL] [Abstract][Full Text] [Related]
40. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
